1. Lee IT, Sansone S, Irfan M, et al. Implementation of international guidelines for polycystic ovary syndrome: barriers and facilitators among gynecologists and primary care providers. F S Rep. 2022;3(2):94–101.
2. Guan C, Zahid S, Minhas AS, et al. Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease. Fertil Steril. 2022;117(5):924–35.
3. Shojaeian Z, Sadeghi R, Latifnejad Roudsari R. Calcium and vitamin D supplementation effects on metabolic factors, menstrual cycles and follicular responses in women with polycystic ocvary syndrome: a systematic review and meta-analysis. Caspian J Intern Med. 2019;10(4):359–69.
4. Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: what’s new?[J]. Adv Clin Exp Med. 2017;26(2):359–67.
5. Ibáñez L, Oberfield SE, Witchel S, et al. An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr. 2017;88(6):371–95.